Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies.

Schuler E, Boughoufala S, Rautenberg C, Nachtkamp K, Dienst A, Fenk R, Haas R, Kondakci M, Germing U, Schroeder T, Kobbe G.

Ann Hematol. 2019 May;98(5):1225-1235. doi: 10.1007/s00277-019-03670-6. Epub 2019 Mar 29.

PMID:
30923997
2.

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.

Hüttmann A, Rekowski J, Müller SP, Hertenstein B, Franzius C, Mesters R, Weckesser M, Kroschinsky F, Kotzerke J, Ganser A, Bengel FM, La Rosée P, Freesmeyer M, Höffkes HG, Hertel A, Behringer D, Prange-Krex G, Griesshammer M, Holzinger J, Wilop S, Krohn T, Raghavachar A, Maschmeyer G, Brink I, Schroers R, Gaska T, Bernhard H, Giagounidis A, Schütte J, Dienst A, Hautzel H, Naumann R, Klein A, Hahn D, Pöpperl G, Grube M, Marienhagen J, Schwarzer A, Kurch L, Höhler T, Steiniger H, Nückel H, Südhoff T, Römer W, Brinkmann M, Ose C, Alashkar F, Schmitz C, Dürig J, Hoelzer D, Jöckel KH, Klapper W, Dührsen U.

Ann Hematol. 2019 Apr;98(4):897-907. doi: 10.1007/s00277-018-3578-0. Epub 2019 Jan 4.

PMID:
30610279
3.

Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation.

Rautenberg C, Pechtel S, Hildebrandt B, Betz B, Dienst A, Nachtkamp K, Kondakci M, Geyh S, Wieczorek D, Haas R, Germing U, Kobbe G, Schroeder T.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2337-2343. doi: 10.1016/j.bbmt.2018.05.011. Epub 2018 May 16.

PMID:
29753838
4.

Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT.

Rautenberg C, Nachtkamp K, Dienst A, Schmidt PV, Heyn C, Kondakci M, Germing U, Haas R, Kobbe G, Schroeder T.

Eur J Haematol. 2017 Apr;98(4):348-354. doi: 10.1111/ejh.12832. Epub 2017 Feb 2.

PMID:
27893163
5.

Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis.

Wilk CM, Heinzler N, Boquoi A, Cadeddu RP, Strapatsas T, Dienst A, Majidi F, Deenen R, Bruns I, Schroeder T, Köhrer K, Haas R, Kobbe G, Fenk R.

Int J Cancer. 2016 Nov 15;139(10):2343-52. doi: 10.1002/ijc.30257. Epub 2016 Aug 13.

6.

Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.

Schroeder T, Rachlis E, Bug G, Stelljes M, Klein S, Steckel NK, Wolf D, Ringhoffer M, Czibere A, Nachtkamp K, Dienst A, Kondakci M, Stadler M, Platzbecker U, Uharek L, Luft T, Fenk R, Germing U, Bornhäuser M, Kröger N, Beelen DW, Haas R, Kobbe G.

Biol Blood Marrow Transplant. 2015 Apr;21(4):653-60. doi: 10.1016/j.bbmt.2014.12.016. Epub 2014 Dec 23.

7.

Optical excitation of Josephson plasma solitons in a cuprate superconductor.

Dienst A, Casandruc E, Fausti D, Zhang L, Eckstein M, Hoffmann M, Khanna V, Dean N, Gensch M, Winnerl S, Seidel W, Pyon S, Takayama T, Takagi H, Cavalleri A.

Nat Mater. 2013 Jun;12(6):535-41. doi: 10.1038/nmat3580. Epub 2013 Mar 24.

PMID:
23524373
8.

Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation.

Schroeder T, Fröbel J, Cadeddu RP, Czibere A, Dienst A, Platzbecker U, Bug G, Uharek L, Fenk R, Germing U, Kröger N, Haas R, Kobbe G.

Leukemia. 2013 Sep;27(9):1910-3. doi: 10.1038/leu.2013.64. Epub 2013 Mar 1. No abstract available.

PMID:
23519388
9.

Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid.

Kuendgen A, Bug G, Ottmann OG, Haase D, Schanz J, Hildebrandt B, Nachtkamp K, Neukirchen J, Dienst A, Haas R, Germing U, Gattermann N.

Clin Epigenetics. 2011 Aug;2(2):389-99. doi: 10.1007/s13148-011-0031-9. Epub 2011 Apr 8.

10.

Light-induced superconductivity in a stripe-ordered cuprate.

Fausti D, Tobey RI, Dean N, Kaiser S, Dienst A, Hoffmann MC, Pyon S, Takayama T, Takagi H, Cavalleri A.

Science. 2011 Jan 14;331(6014):189-91. doi: 10.1126/science.1197294.

11.

Illness representations of depression and perceptions of the helpfulness of social support: comparing depressed and never-depressed persons.

Vollmann M, Scharloo M, Salewski C, Dienst A, Schonauer K, Renner B.

J Affect Disord. 2010 Sep;125(1-3):213-20. doi: 10.1016/j.jad.2010.01.075. Epub 2010 Feb 26.

PMID:
20189252
12.

Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia.

Safaian NN, Czibere A, Bruns I, Fenk R, Reinecke P, Dienst A, Haas R, Kobbe G.

Leuk Res. 2009 Feb;33(2):348-50. doi: 10.1016/j.leukres.2008.04.017. Epub 2008 Jun 24.

PMID:
18573526
13.

Mean first passage time for a class of non-Markovian processes.

Dienst A, Friedrich R.

Chaos. 2007 Sep;17(3):033104.

PMID:
17902986
14.

Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins.

Dienst A, Grunow A, Unruh M, Rabausch B, Nör JE, Fries JW, Gottstein C.

J Natl Cancer Inst. 2005 May 18;97(10):733-47.

PMID:
15900043
15.

Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides.

Philipp J, Dienst A, Unruh M, Wagener A, Grunow A, Engert A, Fries JW, Gottstein C.

Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):905-10. Epub 2003 Mar 20.

PMID:
12649087

Supplemental Content

Loading ...
Support Center